Fundraising Fox
Auricle
YC W21San Francisco, US · Founded 2020 · Delaware corporation · 2 employees · 7 known investors
Find your way into Auricle
Sign up to see every warm intro you have to Auricle
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Auricle team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Auricle develops a neurostimulation implant designed to restore hearing for patients who do not benefit from hearing aids or existing solutions.
Also known as Auricle Health Inc.
Deep TechHealthtechMedical DevicesHard TechNeurotechnologyHealth TechHealthcareUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W21)
Auricle was founded in 2020 by Francis Wong and Jay Dhuldhoya.
FW
Francis WongCo-founder & CEOFrancis Wong is a surgeon who trained in the UK and practiced in the National Health Service for five years before relocating to California for graduate studies at UC Berkeley (MBA/MPH). He has held product management roles at 23andMe and Castlight Health, founded Outcomes, Inc., a digital health company, and worked at Haven prior to co-founding Auricle through the Stanford Biodesign Fellowship.
JD
Jay DhuldhoyaCo-founder · Chief Technology Officer2020–2025Jay Dhuldhoya holds a BA from Columbia and an MS in biomedical engineering from Rice. He previously led R&D, quality, and manufacturing projects at Element Science, a Class 3 medical device startup in San Francisco, and completed the Stanford Biodesign Innovation Fellowship before co-founding Auricle.
JT
Jonathan T. PearsonNamed on SEC filing
Investors · 7
StartX✓ confirmed by AuriclePalo Alto · $10K – $1M
How we know: the company's own site · StartX's portfolio page · Not right? Tell us
Y Combinator✓ confirmed by AuricleSan Francisco · $500K
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
Agrolimen Venturesreported
How we know: Y Combinator's founder network · Not right? Tell us
FAST — by GETTYLABreportedSan Francisco · $100K
How we know: Y Combinator's founder network · Not right? Tell us
Metsu Capitalreported
How we know: Y Combinator's founder network · Not right? Tell us
North South VenturesreportedToronto
How we know: Y Combinator's founder network · Not right? Tell us
Also in the syndicate · 1
Microsoft M12lead
Reported raises · per SEC filings
Form D private placements$350K disclosed across 1 of 2 rounds · 2021–2023
▶$350KraisedNov 2021 · 3 investors · Other TechnologyRule 506(b)
▶$350KraisedNov 2021 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan T. PearsonExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $350K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Images
Related companies · 5
Torpedo TherapeuticsTorpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.
Voyage BiomedicalVoyage Biomedical develops medical device technology that uses cooling to prevent brain damage during stroke. The company was acquired by Penumbra (NYSE:PEN).
Actipulse NeuroscienceActipulse Neuroscience develops non-invasive brain stimulation technologies using high-frequency magnetic pulses to treat central nervous system disorders, including major depressive disorder and neurodegenerative diseases. The company conducts clinical research on transcranial neuromodulation devices.
Well PrincipledWell Principled builds BODYSIM, a fitness forecasting system that uses "digital twin" technology combining sensor fusion with metabolic and physiological science to model body composition, energy expenditure, and hormone balance. The company's core technology translates academic research into simulations, with applications spanning consumer fitness and enterprise models of consumer behavior and battery electrochemistry.
Mindstate Design LabsMindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
Companies working in the same space as Auricle.
Legal entities · 1
corporate structureAuricle Health Inc.
In the news
Frequently asked questions
- What does Auricle do?
- Auricle develops a neurostimulation implant designed to restore hearing for patients who do not benefit from hearing aids or existing solutions.
- Who founded Auricle?
- Auricle was founded by Francis Wong, Jay Dhuldhoya in 2020.
- Who are Auricle's investors?
- Auricle's investors include StartX, Y Combinator, Agrolimen Ventures, FAST — by GETTYLAB, Metsu Capital, North South Ventures.
- How much funding has Auricle raised?
- Auricle has disclosed $350K raised across 1 of its 2 known rounds.
- Where is Auricle headquartered?
- Auricle is headquartered in San Francisco, US.